drugset / Trial / NCT06638671

Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity

NCT06638671 ↗

Phase 4 Completed 14 enrolled University of Virginia
RandomizedCrossoverDouble-blindTreatment

Summary

Metformin is the most prescribed blood sugar (glucose)-lowering medication for patients diagnosed with type 2 diabetes mellitus (T2DM). Metformin stimulates glucose uptake in skeletal muscle similar to the effects of exercise, though, some studies report that metformin may decrease exercise capacity. The main question this study looks to answer is: • Does metformin alter exercise capacity? Participants will: * Complete 5 exercise tests on a stationary bike. * Undergo a body composition test. * Take metformin and placebo. * Complete food and symptom logs. The researchers hypothesize that: • Metformin will reduce aerobic capacity.

Timeline

Start
2025-01-31
Primary completion
2026-03-12
Completion
2026-03-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1500 mg Oral

Indications

No indication recorded.